Skip to main content

Gene Transfer in the Cardiovascular System

Experimental Approaches and Therapeutic Implications

  • Book
  • © 1997

Overview

Part of the book series: Developments in Cardiovascular Medicine (DICM, volume 189)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (21 chapters)

  1. Vectors and Gene Transfer Systems: Molecular Aspects of Delivery

  2. Methods for Localizing Gene Transfer: Mechanical Aspects of Delivery

  3. Gene Delivery for Local Vascular Expression

  4. Gene Delivery for Local Cardiac Expression

Keywords

About this book

The goal of gene transfer is protein expression. a process brought about by the insertion of a gene coding for a foreign protein into target cells resulting in the synthesis of the foreign protein For gene therapy, a tmnsferred therapeutic gene must be expressed at a level beneficial for the patient. This chapter provides an introductory overview of the rapidly evolving field of non-viral approaches for gene delivery to rnarnrnalian cells. Although currently there are fewer ongoing clinical trials using non-viral approaches than those using viral based systems, the number of non-viral trials is increasing. The long range goal of some research groups is the development of a genetically engineered artificial virus targeted to specific cells in the human body. An arurual conference, organized by Cambridge Healthtech Institute entitled "Artificial Self-Assembling Systems for Gene Transfer", brings together researchers interested in this field [1]. Assembly of an artificial virus is very complex; other research groups aim to develop simpler delivery systems consisting of a plasmid combined with delivery agents. Viral-based systems are very successful for gene delivery, but despite their successes, viral-based systems have some geneml limitations and system-specific limitations. When employing a viml-based system, the following limitations should be considered: • size limitation of the inserted gene due to packaging constraints (e. g. adenovirus, retrovirus) . • potential tumorigenesis (e. g. retrovirus) • potential for insertional mutagenesis (greater than plasmid based systems) • potential imrnunogenicity (e. g.

Editors and Affiliations

  • Krannert Institute of Cardiology, Indiana University Medical Center, Indianapolis, USA

    Keith L. March

  • R. L. Roudebush VA Medical Center, Indianapolis, USA

    Keith L. March

Bibliographic Information

  • Book Title: Gene Transfer in the Cardiovascular System

  • Book Subtitle: Experimental Approaches and Therapeutic Implications

  • Editors: Keith L. March

  • Series Title: Developments in Cardiovascular Medicine

  • DOI: https://doi.org/10.1007/978-1-4615-6277-1

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 1997

  • Hardcover ISBN: 978-0-7923-9859-2Published: 31 March 1997

  • Softcover ISBN: 978-1-4613-7881-5Published: 12 October 2012

  • eBook ISBN: 978-1-4615-6277-1Published: 06 December 2012

  • Series ISSN: 0166-9842

  • Edition Number: 1

  • Number of Pages: XX, 516

  • Topics: Cardiology, Human Genetics

Publish with us